Overview

Neoadjuvant Study of Recombinant Vaccinia Virus to Treat Metastatic Colorectal Carcinoma in Patients Undergoing Complete Resection of Liver Tumors

Status:
Terminated

Trial end date:
2013-03-01

Target enrollment:

Participant gender:

Summary

This is a neoadjuvant Phase 2a, open-label trial in patients with metastatic colorectal carcinoma who are undergoing a complete resection of the metastatic colorectal tumors in their liver.

Phase:

Phase 2

Details

Lead Sponsor:

Jennerex Biotherapeutics

Treatments:

Molgramostim
Sargramostim